In recent years, the outcome of tumor-growth has increasingly been in terpreted from the tumor-host relationship. Some tumor-factors such as malignancy, antigenicity of tumor, etc., contribute to determining the relation. Our immunological research on experimental and human cancers revealed appearance of cancer antigen and loss of organ specific antigen in cancer tissues. Several host factors may also contribute to host resistance, such as hormonal regulation. reticuloendothelial activity, antibody titers, etc. Among the above-mentioned factors, none can be independently indicative of the host resistance.
The author's experience on cancer auto-transplantation shows that, although it does not promise a better prognosis. it is useful in the evaluation of the degree of relapse and metastasis of tumors in the abdominal cavity.
The author believes that a safe and simple aid for the diagnosis of cancer relapse is offered by the auto-transplantation.
Immunological aspect of tumors and its relationship to cancer auto-transplantation is also discussed.
Until recently cancer cells had been considered to be characterized by their autonomous growth and development from the pathological standpoint. As a consequence attention was directed solely to the degree of malignancy of the tumor cells, and tumor-bearing organisms were believed to offer no resistance against tumor growth.',' The organisms develop thus cachexia and finally succumb to the disease. It was generally accepted that slight interstitial reaction was the only sign of resistance on the side of the tumor-bearing host against the tumor, and even this reaction was apt to be regarded as an expres sion of malignancy of cancer.3.4 At present, however, there is no complete agreement as to the real nature of malignancy.
For the last seven years the author has investigated the antigenic specificity of cancer cells. From experimental and clinical observations, the author has come to the conclusion that the host is exerting an effect to resist tumor growth and development, and that the development of tumor depends on the host-tumor rela tionship. However, it is very difficult to express the resistance of the host by definite criteria, and all criteria in the past were complicated by numerous non-specific reactions. 5, 6 Since our experiments with auto-transplants of cancer tissues have indicated a close correlation between the growth and develop ment of auto-transplanted cancer cells and cancer cells pre-existing and growing in the host, we assume that the outcome of transplants can be used as one of the criteria indicating the interaction between the host and tumor. In the present experiments the author investigated the antigenicity of cancer cells in association with the resistance of the tumor-bearing host on the basis of cancer auto-transplantation. 3 Its implications to the surgical and medical cancer treatment will be discussed.
METHODS AND RESULTS

Cancer Antigen
In Table 3 .
By staining with the fluorescent antibody technique, we could confirm a specific behavior in none of the cancer cells. In other words, the antigenicity of human cancer varied from case to case, and the result led to the conclusion that cancer specific antigens were very weak in nature, if they existed at all.
Host Resistance
For a long time, the attention of investigators has been engaged in the interstitial reaction of cancerous tissue, stromal reaction, the function of the reticuloendothelial system, hemopoietic activities, nutritional condition (or TABLE 2. Methods of immunization for rabbits factors), hormonal activities, enzymatic activities , antibody formation, serum antibody, cellular antibody, graft-rejection and delayed hypersensitivities .3,7,1 The reticuloendothelial system is concerned with the resistance against cancerous tissues, and there is reported that the stimulation of the reticuloendothelial system may enable the host to increase its resistance against cancer . 9 The hemopoietic capacity and the nutritional condition belong to nonspecific resistance of the host and may have some correlation with the progress of cancer growth. In connection with the treatment of cancer , particularly with tumors of the reproductive organs, specific suppression of tumor growth by to 18 months after transplantation. Of the group which took grafts within 6 months after transplantation, practically all the cases died within 3 months from the date of 'take'. In other words, it was likely that the resistance had been lowered considerably after the first operation against the tumor. Autopsies on these cases showed that most of the deaths occurred under peritonitis due to cancer dissemination. In the majority of the patients who 'took' after 6 months, the take of the graft became perceptible only after 10 months. At this stage subjective symptoms were found in none of the cases, although there were a few cases of recurrence as confirmed from the local symptoms and clinical examinations. Most of them died within 3 months after the grafts were taken.
Of all the cases thus examined an analysis of the antigen was performed by the gel diffusion method on 20 cases in which tumors could be resected. From the analysis, it was found that in the group of 'take' in the early stages normal organ antigens was partly lost in cancerous tissues. On the other hand, in the group which failed to take the grafts, most of the tumors had antigens which were not found in normal tissues. Gain or loss of cancer antigens is a complex problem, and strictly speaking, it is impossible to say that the cancerous tissue has simply gained or lost antigenicity. In 35 per cent of the cases, a loss of tumor antigenicity was confirmed, and most of them took the graft in the early stages after transplantation. In 15 per cent of the cases in which antigenic gain was confirmed, a delay in the 'take' of the graft was observed. In the remaining 50 per cent of the cases both gain and loss of the antigenicity were confirmed. In the majority of the cases there was a partial loss of normal organ specific antigen and at the same time a gain in antigenicity of cancer tissue anew; but even out of these cases some took grafts at early stage and others took only after a long period. One can say that a loss of antigenicity is induced in the majority of cases where tumors can be removed and the grafts are found to be taken in the early stage of the grafting. If one interprets the phenomenon from the standpoint of the host's resistance, one must first deal with the problem of serum antibody. Of the cases which took in the early stage, the aggultination titers dropped in a short period, but the agglutination titers of those cases which failed to take were maintained at a high level.
In the terminal stage of cancer patients a considerable rise in 'Congo-red index' was observed as compared with the normal subjects. Comparison between the cases of positive and negative 'take' of grafts revealed no difference in the index. It was impossible to predict the 'take' of the grafts on the basis of the index of recipients. It is questionable whether decreased functional capacity of the reticuloendothelial system is responsible for decreased host's resistance against cancer. In numerous cases, however, it was possible to suspect postoperative recurrence and metastasis in the peritoneal cavity from the behavior and development of the auto-transplants of cancer. From these observations the author believes that the behavior of the auto-transplants of cancer can be used as an important index for the diagnosis of the recurrence of cancer and the prognosis of the patient. A large metastatic tumor in a lymph node was found, but recurrence of the cancer was not observed in the liver or at the site of the anastomosis.
Recurrence and Its Correlations with Cancer Autografts
The metastatic tumor was removed and the patient is in a good condition up to the present.
The third case is that of a 51-year-old male who was operated on for gastric cancer. Gastrectomy was performed and tumor specimens for autograft were taken. The patient visited the hosptial again with complaints of anorexia three months later. The graft had attained the size of a pea at that time. Reoperation was performed and no tumor was found at the site of the anastomosis or the residual stomach, but disseminated metastatic cancerous lesions were found in the mesentery.
DISCUSSION
The probability for successful radical surgical management of relapsing gastric cancer is very low. On account of the complexity of pathologic features of gastric cancer, not all the cases of relapsing gastric cancer belong to the indica tion of surgery. But, in some types of relapse of gastric cancer, radical opera tion can be fully successfully, only if the indications are adequately decided. Such local relapse as in the stump area of the residual stomach (mostly in the area of anastomosis) or in the regional lymph nodes may be regarded as indicative of feasible reinstitution of radical operation. When the relapse in the residual stomach causes a stenosis of the anastomosed area, which admits of relatively easy clinical diagnosis, the case can be subjected to radical reoperation. Remote metastasis, mainly in the peritoneum, excludes of course the possibility of radical reoperation. In these instances, the initial operation against cancer has to be reinforced by other treatments including the use of anti-cancer agents. Even if surgical operations are carried out with great care, the presence of factors more or less beyond control such as cancer cells in the blood stream may complicate the postoperative course of cancer patients. Biological relationship between the host and cancer cells influences also the prognosis. A problem which demands an especially meticulous approach is the relapse in the regional lymph nodes. Clinical diagnosis of this condition is very difficult. If not discovered in time, extensive lymph-node metastasis and remote metastasis develop and frustrate the effort of repeated radical operations.' In view of such clinical courses where cancer relapse is difficult to demonstrate by conventional clinical and laboratory examinations, we have suggested the use of autotransplant graft as a useful indicator.
The probability of success from radical reoperation is generally believed to be low in the cases of relapse within short periods after the first operation. While the cancer cells are in such a state, chemotherapeutic agents are expected to be effective. The chemotherapeutic agents will, on the contrary, hardly exert their influence upon the original tumor that has not yet acquired much tumor-specific antigenicity, especially when the tumor shows only loss and no gain in its antigenicity. When cancer progresses and proliferates, it gradually affects the reticuloendothelial system. During this process, the antigen becomes excessive, resulting in the inhibition of antibody formation. As a consequence, the cancer becomes more proliferative. At this stage, the transplanted cancer auto-graft may be regarded as 'self', and consequently it ' takes'.
Even though the results of our auto-transplantations of cancer have in dicated the possibility or obtaining auto-immunity to cancer cells, the produc tion of antibodies was not observed to such an extent as to inhibit the growth of the original cancer. However, there has been noted a parallelism between the establishment of the transplanted graft and the growth of the original cancer tissues. In this respect, our method is useful in early detection of cancer recurrence, when the patients are instructed to palpate the transplants and to present themselves to medical examination in cases of growing transplants.
CONCLUSIONS
1) The rate of cure of gastric cancer will rise through an early diagnosis of relapse after surgical operations and by means of the so-called second look operations.
2) Auto-transplantation of cancer does not promise an improvement of clinical course but is useful in evaluating the prognosis of cancer patients. The behavior of the transplanted tumor tissue provides reliable information about cancer recurrence and metastasis in the abdominal cavity.
3) An early diagnosis of relapse of gastric cancer is otherwise very difficult. In this respect, the auto-transplantation of cancer offers a safe and simple, but useful diagnostic aid.
4) The observation of the auto-transplanted graft has led to the conclusion that the antigenicity of gastric cancer is not constant, but varies according to the stages of cancer growth even in one and the same subject.
